1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program is sponsored by Multiple nonprofit funders (jointly launched). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Save a search for “Multiple nonprofit funders (jointly launched)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research | Parkinson's Disease Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research The Alzheimer’s Association and The Michael J.
Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program. U.S. federal government-sponsored research funding has experienced a series of changes that challenges ongoing research initiatives and the future of the U.S. biomedical research enterprise.
Maintaining continuity of funding for these projects enables further scientific progress and is critical to millions of Americans affected by Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders and age-related causes of dementia — and millions more who may be affected by these diseases in the future, as rates for neurological disease are increasing around the world and expected to double as age is the biggest risk factor.
Recent advances in Alzheimer’s and Parkinson’s disorders research show tremendous promise, and ensuring funding for priority research grants is vital for investigators to effectively and efficiently perform life-saving research and carry- out public health programs toward better health outcomes for the United States — and the world.
As the world’s largest nonprofit funders with a shared commitment and purpose to deliver better treatments and a cure for (respectively) Alzheimer’s, Parkinson’s and related disorders, the Alzheimer’s Association and The Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program.
The Alzheimer’s Association has partnered with the Robertson Foundation to support this unique funding program.
This program specifically aims to 1) ensure support for early career researchers (based on NIH definition), who have not yet had the opportunity to fully establish their labs and position their projects for ongoing funding, and 2) provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, Frontotemporal Dementia, Parkinson’s disease, Dementia with Lewy Bodies, atypical Parkinson's and/or other related disorders that have been impacted by a series of changes at NIH.
Funding and award period: Principal investigators may apply for bridge funding spanning 3 to 12 months for U.S. and international projects impacted by changes in the NIH. Specific streams of funding include: Delayed Review: Projects stalled due to NIH review process delays. Termination: Laboratories whose NIH grants have been terminated due to changes in funding priorities and/or area of interest and are seeking other permanent funding.
Priority Misalignment: Projects that no longer fit NIH focus areas requiring redirection to align with reframing to reflect adjusted priorities and areas of interest. Gaps: Previously funded projects awaiting reapproval under new criteria. Personnel Continuity: Salary support for key personnel due to changes in project timelines.
Here. Until Parkinson's isn't. Help us speed a cure for the 6 million people worldwide living with Parkinson's.
Join our email list to get the latest news and resources directly to your inbox. Connection to Parkinson's Immediate family member has PD Immediate family member had PD Extended family member or friend has PD Extended family member or friend had PD I am a researcher, clinician or work with the PD community What Year Were You Diagnosed with PD?
Based on current listing details, eligibility includes: Early career researchers studying neurodegenerative diseases. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.